Browsing by Yonsei Author : Lee, Yong Ho

eperson profile image
Name:
Lee, Yong Ho [이용호]
orcid http://orcid.org/0000-0002-6219-4942
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (56424219700)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 205

This table browses all dspace content
Issue DateTitleJournal Title
2022A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiomeHEPATOLOGY
2022Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes YONSEI MEDICAL JOURNAL
2022Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease BIOMEDICINES
2022The predicting value of resting heart rate to identify undiagnosed diabetes in Korean adult: Korea National Health and Nutrition Examination Survey EPIDEMIOLOGY AND HEALTH
2022Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21 FRONTIERS IN IMMUNOLOGY
2022Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort StudyJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2022Ideal cardiovascular health duration and risk of chronic kidney disease and cardiovascular diseaseHEART
2022Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations DIABETES & METABOLISM JOURNAL
2022Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) BMC MEDICINE
2022Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease GUT AND LIVER
2022State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis Endocrinology and Metabolism(대한내분비학회지)
2022Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease JAMA NETWORK OPEN
2022Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2022Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million PeopleHYPERTENSION
2021The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011) Endocrinology and Metabolism(대한내분비학회지)
2021Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes FRONTIERS IN CARDIOVASCULAR MEDICINE
2021Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetesDIABETES RESEARCH AND CLINICAL PRACTICE
2021Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway DIABETES & METABOLISM JOURNAL
2021Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO) Clinical Hypertension
2021Association of circulating metabolites with incident type 2 diabetes in an obese population from a national cohortDIABETES RESEARCH AND CLINICAL PRACTICE
2021Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort StudyCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021Body Weight Variability: A Marker for Increased Risk or a Causative Factor for Dementia? JOURNAL OF OBESITY & METABOLIC SYNDROME
2021Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus FRONTIERS IN NEUROSCIENCE
2021Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts Endocrinology and Metabolism(대한내분비학회지)
2021Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetesJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021Risks and Prognoses of Alzheimer's Disease and Vascular Dementia in Patients With Insomnia: A Nationwide Population-Based Study FRONTIERS IN NEUROLOGY
2021Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetesDIABETES OBESITY & METABOLISM
2021Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)AUTOPHAGY
2021O- Linked N-Acetylglucosamine Modification of Mitochondrial Antiviral Signaling Protein Regulates Antiviral Signaling by Modulating Its Activity FRONTIERS IN IMMUNOLOGY
2021Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trialDIABETES OBESITY & METABOLISM
2020Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2020Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis BDIGESTIVE AND LIVER DISEASE
2020Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
2020SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicityAUTOPHAGY
2020Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression SCIENTIFIC REPORTS
2020Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH) BIOMOLECULES
2020Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetesDIABETES & METABOLISM
2020Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale ProteomicsDIABETES CARE
2020Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes MEDICINE
2020Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetesATHEROSCLEROSIS
2020Glucose Loading Enhances the Value of 18 F-FDG PET/CT for the Characterization and Delineation of Cerebral Gliomas CANCERS
2020Response: Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J 2020;44:267-76) DIABETES & METABOLISM JOURNAL
2020O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
2020Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association DIABETES & METABOLISM JOURNAL
2020Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study CARDIOVASCULAR DIABETOLOGY
2020Anti-Inflammatory Effect for Atherosclerosis Progression by Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor in a Normoglycemic Rabbit Model KOREAN CIRCULATION JOURNAL
2020SGLT2 Inhibition Modulates NLRP3 Inflammasome Activity via Ketones and Insulin in Diabetes With Cardiovascular Disease NATURE COMMUNICATIONS
2020Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes SCIENTIFIC REPORTS
2020Association Between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2020Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular RiskAMERICAN JOURNAL OF GASTROENTEROLOGY

Browse

Links